FourThought Financial’s Charles River Laboratories CRL Stock Holding History

FourThought Financial’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$50K	Buy	256 +45	+21%	+$9.71K	0.01%	609
2022 Q2	$45K	Sell	211 -2	-0.9%	-$489	0.01%	636
2022 Q1	$60K	Hold	213	–	–	0.01%	608
2021 Q4	$80K	Sell	213 -43	-17%	-$16.7K	0.01%	529
2021 Q3	$105K	Hold	256	–	–	0.01%	475
2021 Q2	$94K	Hold	256	–	–	0.01%	515
2021 Q1	$74K	Sell	256 -3	-1%	-$834	0.01%	572
2020 Q4	$64K	Buy	+259	New	+$61.7K	0.01%	599

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

FourThought Financial's CRL Position: Q3 2022 in Review

FourThought Financial increased its Charles River Laboratories (CRL) stake by 21% in Q3 2022, buying an estimated $9.71K and bringing the position to 256 shares worth $50K. The position accounts for 0.01% of the portfolio, ranked #609.

FourThought Financial first reported a position in CRL in Q4 2020 and has held it in 8 quarters since. The position peaked at $105K in Q3 2021. 584 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

FourThought Financial held 256 shares of Charles River Laboratories worth $50K as of Q3 2022.
FourThought Financial bought 45 Charles River Laboratories shares in Q3 2022, an estimated $9.71K.
Charles River Laboratories made up 0.01% of FourThought Financial's portfolio in Q3 2022, its #609 holding.
FourThought Financial first reported a position in Charles River Laboratories in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's Charles River Laboratories position peaked at $105K in Q3 2021.
584 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.